Get the Stockscreener App
9.6396
0.86%
0.0496
Indivior Plc stock is traded at $9.6396, with a volume of 259.81K.
It is up +0.86% in the last 24 hours and down -1.60% over the past month.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
See More
Previous Close:
$9.59
Open:
$9.7
24h Volume:
259.81K
Relative Volume:
0.30
Market Cap:
$1.20B
Revenue:
$1.12B
Net Income/Loss:
$5.00M
P/E Ratio:
963.96
EPS:
0.01
Net Cash Flow:
$-383.00M
1W Performance:
-0.29%
1M Performance:
-1.60%
6M Performance:
-2.30%
1Y Performance:
-53.39%
1-Day Range:
$9.59
$9.92
1-Week Range:
$9.02
$10.10
52-Week Range:
$7.33
$22.53
Indivior Plc Stock (INDV) Company Profile
Compare INDV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
9.63 | 1.20B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
159.32 | 71.40B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.11 | 47.36B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.17 | 46.03B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.33 | 18.86B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.25 | 13.96B | 612.78M | -86.37M | -62.91M | -0.87 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jul-23-24 | Initiated | Piper Sandler | Overweight |
| Apr-03-24 | Initiated | Craig Hallum | Buy |
| Jul-13-23 | Initiated | Northland Capital | Outperform |
Indivior Plc Stock (INDV) Latest News
Madison Avenue Partners Increases Stake in Indivior PLC - TipRanks
Global Naloxone Market to Witness Remarkable Growth with Indivior PLC, Akorn, Inc., Hikma Pharmaceuticals PLC, - EIN News
Indivior Announces Joseph Ciaffoni Appointed Chief Executive Off - GuruFocus.com
Indivior CEO’s Share Interests Updated Following LTIP Award Release - TipRanks
Indivior Director Increases Shareholding, Signaling Confidence - TipRanks
(INDV) Technical Data - Stock Traders Daily
Indivior PLC Grants Long-Term Incentive Awards to Key Executives - TipRanks
Investors who lost money on Indivior PLC(INDV) should contact Levi & Korsinsky about pending Class ActionINDV - ACCESS Newswire
Indivior Executive and Associate Increase Shareholding - TipRanks
Decoding Indivior PLC (INDV): A Strategic SWOT Insight - GuruFocus.com
Investors in Indivior PLC Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights – INDV - ACCESS Newswire
Indivior Announces Further Changes to Board of Directors - GuruFocus.com
Indivior streamlines board ahead of AGM - Investing.com India
Indivior streamlines board ahead of AGM By Investing.com - Investing.com South Africa
Indivior PLC Announces Change in Major Holdings - TipRanks
Shareholder Rights Advocates at Levi & Korsinsky Investigate Indivior PLC (INDV) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Indivior PLC Announces Vesting of Long-Term Incentive Plan Awards - TipRanks
Indivior shrinks board following pressure from activist investor - ShareCast
Indivior Announces Strategic Board Restructuring - TipRanks
REGIndivior PLCFurther Changes to Board of Directors - TradingView
Earnings To Watch: Indivior PLC (INDV) Reports Q4 2024 Result - GuruFocus.com
Indivior PLC Updates on Total Voting Rights and Capital - TipRanks
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Indivior PLC(INDV) Shareholders - ACCESS Newswire
Is Indivior PLC (INDV) the Best Small Cap Pharma Stock to Buy Now? - Insider Monkey
Insider Spends US$399k Buying More Shares In Indivior - Simply Wall St
Shareholders that lost money on Indivior PLC(INDV) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
VELA Investment Management LLC Has $2.26 Million Stock Position in Indivior PLC (NASDAQ:INDV) - MarketBeat
Indivior (NASDAQ:INDV) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Richmond InnoChesterfield pharma company Indivior announces CEO change - The Business Journals
Stockpickers: Indivior highlights the difficulty of finding a cure - Financial Times
Investors in Indivior PLC Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your RightsINDV - ACCESS Newswire
(INDV) Investment Analysis - Stock Traders Daily
Indivior Director Acquires 15,000 Shares, Signaling Confidence - TipRanks
Levi & Korsinsky Notifies Shareholders of Indivior PLC(INDV) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Shareholders that Lost Money on Indivior PLC (INDV) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Indivior FY2025 EPS Estimate Lowered by Northland Capmk - MarketBeat
Indivior PLC Sees Change in Major Shareholding as Morgan Stanley Adjusts Position - TipRanks
Indivior CEO exits as activist shareholder Oaktree presses for change - BioCentury
Class Action Filed Against Indivior PLC (INDV) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
Indivior Director Increases Stake with Share Purchase - TipRanks
Indivior Chair Acquires 10,000 Shares, Signaling Confidence in Company’s Future - TipRanks
Indivior names former Collegium Pharmaceutical chief as CEO -February 27, 2025 at 09:48 am EST - Marketscreener.com
Indivior CEO Mark Crossley to step down, Joe Ciaffoni to succeed - TipRanks
Indivior names Joseph Ciaffoni as new CEO By Investing.com - Investing.com Canada
Pharma veteran Ciaffoni to take CEO reins at Indivior - ShareCast
Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer - The Malaysian Reserve
Indivior names Joseph Ciaffoni as new CEO - Investing.com India
UK's Indivior appoints Joe Ciaffoni as CEO - Reuters.com
Indivior Appoints Joe Ciaffoni as New CEO to Drive Growth - TipRanks
Indo-Asian News Service-INDIVIOR ANNOUNCES JOSEPH CIAFFONI APPOINTED CHIEF EXECUTIVE OFFICER - IANS India Pvt Ltd
Indivior PLC Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your RightsINDV - ACCESS Newswire
Indivior Plc Stock (INDV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.16%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):